ACEI / ARB+finerenone
BRWEP2024W102100109
Approved small_molecule active
Quick answer
ACEI / ARB+finerenone for Henoch Schönlein Purpura Nephritis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Henoch Schönlein Purpura Nephritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active